Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

Dyax, Trubion expand research
June 2007
SHARING OPTIONS:

CAMBRIDGE, Mass.Dyax Corp. announced recently that Trubion Pharmaceuticals Inc. has exercised an option to expand its existing research agreement, which covers protein therapeutics and diagnostics discovery. In addition to the ongoing multiple-target funded research project, Dyax will now transfer its proprietary phage library to Trubion's facility for use in identifying therapeutic leads to additional targets, further enabling Trubion's ability to rapidly design and develop product candidates for a range of disease targets. Additional terms of the expanded agreement were not disclosed. 

Back



PAGE UTILITIES


CONTACT US
DDNEWS
1000 N West Street, Suite 1200,
Wilmington, Delaware, 19801
Ph: 888-781-0328 |  Fax: 705-528-0270
 
© Copyright 2020 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.